Switch to:
More From Other Websites
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN) Nov 25 2014
Lixte Biotech: A Novel Approach to Boost Existing Cancer Therapies Nov 18 2014
Seattle Genetics Names New General Counsel and Executive Vice President, Legal Affairs Nov 18 2014
Seattle Genetics Names New General Counsel and Executive Vice President, Legal Affairs Nov 18 2014
Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) Nov 18 2014
SEATTLE GENETICS INC /WA Financials Nov 14 2014
10-Q for Seattle Genetics, Inc. Nov 09 2014
SEATTLE GENETICS INC /WA Files SEC form 10-Q, Quarterly Report Nov 07 2014
Seattle Genetics to Present Clinical Data from Broad ADCETRIS® (Brentuximab Vedotin) Development... Nov 07 2014
Seattle Genetics (SGEN) Shows Signs Of Being Water-Logged And Getting Wetter Nov 06 2014
Seattle Genetics to Present at Credit Suisse Healthcare Conference Nov 04 2014
Seattle Genetics to Present at Credit Suisse Healthcare Conference Nov 04 2014
Seattle Genetics Gains on Narrower-than-Expected Q3 Loss Nov 03 2014
Seattle Genetics beats Street 3Q forecasts Oct 30 2014
Seattle Genetics Reports Third Quarter 2014 Financial Results Oct 30 2014
Seattle Genetics Inc Earnings Call scheduled for 4:30 pm ET today Oct 30 2014
SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 30 2014
Seattle Genetics Reports Third Quarter 2014 Financial Results Oct 30 2014
Q3 2014 Seattle Genetics Inc Earnings Release - After Market Close Oct 30 2014
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use Oct 27 2014
Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths Oct 15 2014
Seattle Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2014 Financial... Oct 14 2014
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma Oct 03 2014
The Zacks Analyst Blog Highlights: Super Micro Computer, Horizon Pharma, Phibro Animal Health,... Oct 02 2014
Will This Analyst Downgrade Hurt Seattle Genetics (SGEN) Stock Today? Sep 30 2014
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS®... Sep 29 2014
Nasdaq stocks posting largest percentage decreases Apr 14 2014
Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial... Apr 08 2014
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Clinical Data at the 2014 Bone Marrow... Feb 27 2014
Seattle Genetics Reports Fourth Quarter and Year 2013 Financial Results Feb 12 2014
Seattle Genetics Announces Executive Promotions and Management Addition Feb 10 2014
Seattle Genetics to Present at Upcoming Investor Conferences Feb 06 2014
Seattle Genetics Achieves Sales Milestone Under ADCETRIS® (Brentuximab Vedotin) Collaboration with... Feb 05 2014
Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2013... Jan 23 2014
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for the Treatment of... Jan 17 2014
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for the Treatment of... Jan 17 2014
Seattle Genetics Highlights Key 2014 Milestones and Activities at J.P. Morgan Healthcare Conference Jan 13 2014
Seattle Genetics and AbbVie broaden partnership Jan 08 2014
Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with AbbVie Jan 08 2014
Seattle Genetics to Present at the J.P. Morgan Healthcare Conference Jan 06 2014
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Phase 2 Clinical Data in Diffuse Large... Dec 10 2013
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate (ADC) SGN-CD19A at ASH 2013 Dec 07 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK